Preparation and characterization of HMX/AP co-crystal

被引：0

作者：

Chen, Jie ^{[1
]}

Duan, Xiao-Hui ^{[1
]}

Pei, Chong-Hua ^{[1
]}

机构：

[1] School of Materials Science and Engineering, Southwest University of Science and Technology

来源：

Hanneng Cailiao/Chinese Journal of Energetic Materials | 2013年 / 21卷 / 04期

关键词：

AP; Cocrystal; HMX; Phase diagram; Physical chemistry; Solvent/non-solvent method;

D O I：

10.3969/j.issn.1006-9941.2013.04.001

中图分类号：

学科分类号：

摘要：

Molecular simulation technique was used to study the interaction between HMX and AP molecules. The solubility of AP in dimethyl sulfoxide (DMSO) was determined by weighing method. The solubilities of HMX in pure DMSO solvent and different concentration DMSO solutions of AP were obtained using high performance liquid chromatography (HPLC). The ternary phase diagram of HMX/AP/DMSO at 26°C and normal pressure was obtained through fitting solubility data. Based on the HMX/AP/DMSO ternary phase diagram, the HMX/AP co-crystal was prepared by solvent/non-solvent method and was characterized by scanning electronic microscope (SEM) and powder x-ray diffraction (PXRD). Results show that the morphology of HMX/AP co-crystal is regular long strip and different from the original crystals (HMX, AP). The solubility of HMX/AP co-crystal in water is only 0.034 g/100 mL.

引用

页码：409 / 413

页数：4

共 7 条

[1]

Trask A.V., Samuel M.W.D., William J., Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration, Crystal Growth & Design, 5, 3, pp. 1013-1021, (2005)

[2]

Jones W., Samuel M.W.D., Trask A.V., Pharmaceutical cocrystals: An emerging approach to physical property enhancement, MRS Bulletin, 31, 11, pp. 875-879, (2006)

[3]

Vishweshwar P., Jennifer M.A., Bis J.A., Et al., Pharmaceutical co-crystals, Journal of Pharmaceutical Sciences, 95, 3, pp. 499-516, (2006)

[4]

Blagden N., de Matas M., Gavan P.T., Et al., Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Advanced Drug Delivery Reviews, 59, 7, pp. 617-630, (2007)

[5]

Good D.J., Nair R.H., Solubility advantage of pharmaceutical cocrystals, Crystal Growth & Design, 9, 5, pp. 2252-2264, (2009)

[6]

Levinthal M.L., Propellant made with cocrystals of cyclotetramethylenetetranitramine and ammonium perchlorate: USP 4086110, (1978)

[7]

Xu W.-Y., Xiong J.-A., Jing B.-Y., Performance study of ammonium perchlorate (AP) and octogen (HMX) cocrystal, Journal of Propulsion Technology, 7, 5, pp. 179-181, (1986)

← 1 →